arrow_back Back to App

Training for US Drug Manufacturing Workers

This act aims to boost essential drug production in the United States by establishing training centers. This could lead to greater availability of medicines for citizens and reduce the risk of shortages. Investments in training may also create new job opportunities in the pharmaceutical sector.
Key points
Up to 20 new training centers for biopharmaceutical manufacturing workers will be established.
Centers will train in drug production, including vaccines and sterile operations.
100 million dollars are allocated for the program from 2022-2026, with 20% reserved for minority-serving institutions.
The goal is to enhance drug supply security and create jobs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5993
Sponsor: Rep. Butterfield, G. K. [D-NC-1]
Process start date: 2021-11-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

MEDS in America Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5993.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-11-17.

What are the main provisions?

Key points include:

  • Up to 20 new training centers for biopharmaceutical manufacturing workers will be established.
  • Centers will train in drug production, including vaccines and sterile operations.
  • 100 million dollars are allocated for the program from 2022-2026, with 20% reserved for minority-serving institutions.
  • The goal is to enhance drug supply security and create jobs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Butterfield, G. K. [D-NC-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Labor Education